| Acknowledgment |
|
ix | |
| About the Authors |
|
x | |
| Preface |
|
xi | |
|
Introduction: Models and Concepts |
|
|
1 | (24) |
|
|
|
1 | (1) |
|
|
|
2 | (3) |
|
Language and Cognition (Body Function) |
|
|
5 | (11) |
|
Neural Bases of Language and Cognition (Body Structure) |
|
|
16 | (7) |
|
Summary and Looking Ahead |
|
|
23 | (2) |
|
Overview of Neurogenic Language Disorders |
|
|
25 | (32) |
|
|
|
25 | (1) |
|
|
|
26 | (12) |
|
Right Hemisphere Disorders |
|
|
38 | (8) |
|
|
|
46 | (6) |
|
|
|
52 | (4) |
|
|
|
56 | (1) |
|
Neuropathology of Neurogenic Language Disorders |
|
|
57 | (27) |
|
|
|
57 | (1) |
|
|
|
58 | (9) |
|
|
|
67 | (1) |
|
|
|
68 | (1) |
|
|
|
69 | (5) |
|
|
|
74 | (9) |
|
|
|
83 | (1) |
|
A General Model of Assessment |
|
|
84 | (39) |
|
|
|
84 | (1) |
|
Assessment: Definition and Goals |
|
|
85 | (7) |
|
|
|
92 | (29) |
|
Sharing Assessment Results |
|
|
121 | (1) |
|
|
|
122 | (1) |
|
Assessment of Function: Quantifying and Qualifying Linguistic Disorders |
|
|
123 | (54) |
|
|
|
123 | (1) |
|
General Assessment Procedures |
|
|
124 | (1) |
|
Case History and Observations |
|
|
125 | (4) |
|
Screening or Bedside Procedures |
|
|
129 | (3) |
|
|
|
132 | (11) |
|
Tests of Specific Linguistic Functions |
|
|
143 | (26) |
|
|
|
169 | (1) |
|
Prognostic Factors for Linguistic Outcomes |
|
|
170 | (6) |
|
|
|
176 | (1) |
|
Assessment of Function: Quantifying and Qualifying Cognitive Disorders |
|
|
177 | (39) |
|
|
|
177 | (3) |
|
|
|
180 | (31) |
|
|
|
211 | (1) |
|
Qualitative Assessment Considerations |
|
|
212 | (1) |
|
Prognostic Factors for Cognitive Outcomes |
|
|
213 | (2) |
|
|
|
215 | (1) |
|
Assessment of Activity and Participation and Quality of Life |
|
|
216 | (21) |
|
|
|
216 | (1) |
|
|
|
217 | (2) |
|
|
|
219 | (6) |
|
|
|
225 | (2) |
|
|
|
227 | (6) |
|
Relationships among Measures of Impairment, Function, Participation, and Quality of Life |
|
|
233 | (1) |
|
Authentic Assessment and Ethnography |
|
|
234 | (2) |
|
|
|
236 | (1) |
|
|
|
237 | (17) |
|
|
|
|
|
237 | (1) |
|
|
|
238 | (2) |
|
The Process of Evidence-Based Practice |
|
|
240 | (13) |
|
Current Practices and Future Directions |
|
|
253 | (1) |
|
|
|
253 | (1) |
|
Remediation of Function: Behavioral Approaches |
|
|
254 | (69) |
|
|
|
254 | (1) |
|
Treatment of Linguistic Impairments |
|
|
255 | (40) |
|
Treatment of Cognitive Impairments and Disabilities |
|
|
295 | (26) |
|
Generalization and Transfer of Learning |
|
|
321 | (1) |
|
|
|
322 | (1) |
|
Remediation of Function: Pharmacotherapy Approaches |
|
|
323 | (12) |
|
|
|
323 | (1) |
|
The Basics of Pharmacotherapy: Neurotransmitters |
|
|
324 | (1) |
|
Pharmacological Treatment of Linguistic Impairments |
|
|
325 | (5) |
|
Pharmacological Treatment of Cognitive Impairments |
|
|
330 | (4) |
|
|
|
334 | (1) |
|
Remediation of Activity and Participation |
|
|
335 | (54) |
|
|
|
336 | (1) |
|
Activity-Focused Treatments |
|
|
336 | (37) |
|
Participation-Focused Treatments and Community Resources |
|
|
373 | (5) |
|
Complementary and Alternative Treatments |
|
|
378 | (7) |
|
|
|
385 | (3) |
|
|
|
388 | (1) |
|
Modern Health Care and the Future of Neurogenic Language Disorders |
|
|
389 | (21) |
|
|
|
389 | (1) |
|
|
|
390 | (4) |
|
Impact of Managed Care on Services for Neurogenic Language Disorders |
|
|
394 | (2) |
|
Strategies for Optimizing Services for Neurogenic Language Disorders |
|
|
396 | (4) |
|
Management Strategies across the Continuum of Care |
|
|
400 | (9) |
|
|
|
409 | (1) |
| Glossary |
|
410 | (14) |
| References |
|
424 | (78) |
| Index |
|
502 | |